{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T18:11:53Z","timestamp":1782238313838,"version":"3.54.5"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"NHMRC Centre of Research Excellence in Population Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.schres.2021.08.001","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T05:37:15Z","timestamp":1631079435000},"page":"79-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["The association between vitamin D and symptom domains in psychotic disorders: A systematic review"],"prefix":"10.1016","volume":"237","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1096-3834","authenticated-orcid":false,"given":"Jonathan","family":"Tsiglopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Mifsud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Allott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"O'Donoghue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2021.08.001_bb0005","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.psychres.2016.12.052","article-title":"Correlates of vitamin D in psychotic disorders: a comprehensive systematic review","volume":"249","author":"Adamson","year":"2017","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2021.08.001_bb0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fpsyt.2017.00105","article-title":"Vitamin D levels in different severity groups of schizophrenia","volume":"8","author":"Akinlade","year":"2017","journal-title":"Front. Psychiatry Front. Res. Found."},{"issue":"1","key":"10.1016\/j.schres.2021.08.001_bb0015","first-page":"2","article-title":"Comparison of serum vitamin D levels between patients with deficit and non-deficit schizophrenia","volume":"54","author":"Akyol","year":"2016","journal-title":"Yeni Symposium: psikiyatri, noroloji ve davranis bilimleri dergisi"},{"issue":"12","key":"10.1016\/j.schres.2021.08.001_bb0020","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.4088\/JCP.09m05299yel","article-title":"A cross-sectional study of vitamin D deficiency among immigrants and norwegians with psychosis compared to the general population","volume":"71","author":"Berg","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2021.08.001_bb0025","series-title":"Sunlight, Vitamin D and Skin Cancer","first-page":"55","article-title":"Optimal Serum 25-Hydroxyvitamin D Levels for Multiple Health Outcomes","author":"Bischoff-Ferrari","year":"2008"},{"key":"10.1016\/j.schres.2021.08.001_bb0030","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.schres.2017.08.059","article-title":"The relation of vitamin D, metabolic risk and negative symptom severity in people with psychotic disorders","volume":"195","author":"Bruins","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.08.001_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1092852914000601","article-title":"Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia","volume":"19","author":"Carbon","year":"2014","journal-title":"CNS Spectr."},{"issue":"11","key":"10.1016\/j.schres.2021.08.001_bb0040","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1373\/clinchem.2004.040683","article-title":"How accurate are assays for 25-hydroxyvitamin D? Data from the international vitamin D external quality assessment scheme","volume":"50","author":"Carter","year":"2004","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.schres.2021.08.001_bb0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/eb-2015-102117","article-title":"Vitamin D in schizophrenia: a clinical review","volume":"19","author":"Chiang","year":"2016","journal-title":"Evid. Based Ment. Health"},{"issue":"2\u20133","key":"10.1016\/j.schres.2021.08.001_bb0050","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.schres.2014.08.031","article-title":"Low vitamin D levels predict clinical features of schizophrenia","volume":"159","author":"Cieslak","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.08.001_bb0055","first-page":"7839287","article-title":"Symptomatic correlates of vitamin D deficiency in first-episode psychosis","volume":"2019","author":"Coentre","year":"2019","journal-title":"Psychiatry J. Print"},{"key":"10.1016\/j.schres.2021.08.001_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-021-01025-0","article-title":"Vitamin D and schizophrenia: 20 years on","author":"Cui","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2021.08.001_bb0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neubiorev.2016.03.017","article-title":"A review of vulnerability and risks for schizophrenia: beyond the two hit hypothesis","volume":"65","author":"Davis","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"10","key":"10.1016\/j.schres.2021.08.001_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165284","article-title":"The relationship between symptom severity and low vitamin D levels in patients with schizophrenia","volume":"11","author":"Dogan Bulut","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.schres.2021.08.001_bb0075","first-page":"168","article-title":"Vitamin D deficiency in adult patients with schizophreniform and autism spectrum syndromes: a one-year cohort study at a German tertiary care hospital","volume":"7","author":"Endres","year":"2016","journal-title":"Front. Psychiatry Front. Res. Found."},{"issue":"1","key":"10.1016\/j.schres.2021.08.001_bb0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.yfrne.2012.07.001","article-title":"Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease","volume":"34","author":"Eyles","year":"2013","journal-title":"Front. Neuroendocrinol."},{"issue":"1","key":"10.1016\/j.schres.2021.08.001_bb0085","doi-asserted-by":"crossref","first-page":"17692","DOI":"10.1038\/s41598-018-35418-z","article-title":"The association between neonatal vitamin D status and risk of schizophrenia","volume":"8","author":"Eyles","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.schres.2021.08.001_bb0090","doi-asserted-by":"crossref","DOI":"10.1186\/s12982-015-0037-4","article-title":"Applying the Bradford Hill criteria in the 21st century: how data integration has changed causal inference in molecular epidemiology","volume":"12","author":"Fedak","year":"2015","journal-title":"Emerg. Themes Epidemiol."},{"issue":"6","key":"10.1016\/j.schres.2021.08.001_bb0095","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1093\/schbul\/sbx162","article-title":"Nutritional deficiencies and clinical correlates in first-episode psychosis: a systematic review and meta-analysis","volume":"44","author":"Firth","year":"2018","journal-title":"Schizophr. Bull."},{"issue":"8","key":"10.1016\/j.schres.2021.08.001_bb0100","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00406-018-0932-0","article-title":"Hypovitaminosis D is associated with negative symptoms, suicide risk, agoraphobia, impaired functional remission, and antidepressant consumption in schizophrenia","volume":"269","author":"Fond","year":"2019","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2021.08.001_bb0105","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.psychres.2018.09.024","article-title":"Hypovitaminosis D is associated with depression and anxiety in schizophrenia: results from the national FACE-SZ cohort","volume":"270","author":"Fond","year":"2018","journal-title":"Psychiatry Res."},{"issue":"1\u20133","key":"10.1016\/j.schres.2021.08.001_bb0110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.schres.2016.02.034","article-title":"Subjective quality of life in first-episode psychosis. a ten year follow-up study","volume":"172","author":"Gardsjord","year":"2016","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2021.08.001_bb0115","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12888-019-2059-x","article-title":"Clinical and metabolic response to vitamin D plus probiotic in schizophrenia patients","volume":"19","author":"Ghaderi","year":"2019","journal-title":"BMC Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2021.08.001_bb0120","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/eip.12122","article-title":"Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia","volume":"9","author":"Graham","year":"2015","journal-title":"Early Interv. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2021.08.001_bb0125","doi-asserted-by":"crossref","first-page":"638S","DOI":"10.1093\/ajcn\/61.3.638S","article-title":"Environmental factors that influence the cutaneous production of vitamin D","volume":"61","author":"Holick","year":"1995","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.schres.2021.08.001_bb0130","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.schres.2021.08.001_bb0135","first-page":"88","article-title":"Low serum vitamin D concentrations in patients with schizophrenia","volume":"14","author":"Itzhaky","year":"2012","journal-title":"Israel Med. Assoc. J."},{"issue":"3","key":"10.1016\/j.schres.2021.08.001_bb0140","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/schbul\/sbp023","article-title":"Relation of schizophrenia prevalence to latitude, climate, fish consumption, infant mortality, and skin color: a role for prenatal vitamin d deficiency and infections?","volume":"35","author":"Kinney","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2021.08.001_bb0145","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ebiom.2017.11.027","article-title":"Vitamin D supplementation in chronic schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled clinical trial","volume":"26","author":"Krivoy","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.schres.2021.08.001_bb0150","first-page":"06","article-title":"Low levels of serum vitamin D in clozapine-treated schizophrenia patients are associated with high levels of the proinflammatory cytokine IL-6","volume":"06","author":"Krivoy","year":"2020","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2021.08.001_bb0155","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.schres.2018.08.011","article-title":"Vitamin D and clinical symptoms in first episode psychosis (FEP): a prospective cohort study","volume":"204","author":"Lally","year":"2019","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.08.001_bb0160","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12888-016-0780-2","article-title":"Clinical correlates of vitamin D deficiency in established psychosis","volume":"16","author":"Lally","year":"2016","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2021.08.001_bb0165","article-title":"Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better?","volume":"7","author":"Ma","year":"2020","journal-title":"Mil. Med. Res."},{"issue":"1","key":"10.1016\/j.schres.2021.08.001_bb0170","first-page":"303","article-title":"Role of vitamin D as adjuvant therapy of hypovitaminosis D in patients of schizophrenia","volume":"13","author":"Malik","year":"2019","journal-title":"Pak. J. Med. Health Sci."},{"issue":"5","key":"10.1016\/j.schres.2021.08.001_bb0175","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1600-0447.2010.01551.x","article-title":"Is it time to trial vitamin D supplements for the prevention of schizophrenia?","volume":"121","author":"McGrath","year":"2010","journal-title":"Acta Psychiatr. Scand."},{"issue":"6","key":"10.1016\/j.schres.2021.08.001_bb0180","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/schbul\/sbq101","article-title":"Developmental vitamin D deficiency and risk of schizophrenia: a 10-year update","volume":"36","author":"McGrath","year":"2010","journal-title":"Schizophr. Bull."},{"issue":"18","key":"10.1016\/j.schres.2021.08.001_bb0185","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1056\/NEJMoa1915784","article-title":"Association between mental disorders and subsequent medical conditions","volume":"382","author":"Momen","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.schres.2021.08.001_bb0190","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1017\/S0033291713002973","article-title":"Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosis","volume":"44","author":"Morgan","year":"2014","journal-title":"Psychol. Med."},{"issue":"2","key":"10.1016\/j.schres.2021.08.001_bb0195","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.psychres.2015.10.015","article-title":"Vitamin D status in psychotic disorder patients and healthy controls\u2013the influence of ethnic background","volume":"230","author":"Nerhus","year":"2015","journal-title":"Psychiatry Res."},{"issue":"1\u20133","key":"10.1016\/j.schres.2021.08.001_bb0200","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.schres.2016.08.024","article-title":"Low vitamin D is associated with negative and depressive symptoms in psychotic disorders","volume":"178","author":"Nerhus","year":"2016","journal-title":"Schizophr. Res."},{"issue":"7","key":"10.1016\/j.schres.2021.08.001_bb0205","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.4088\/JCP.16m10880","article-title":"Vitamin D deficiency associated with cognitive functioning in psychotic disorders","volume":"78","author":"Nerhus","year":"2017","journal-title":"J. Clin. Psychiatry"},{"issue":"11","key":"10.1016\/j.schres.2021.08.001_bb0210","doi-asserted-by":"crossref","first-page":"686","DOI":"10.5694\/mja11.10301","article-title":"Vitamin D and health in adults in Australia and New Zealand: a position statement","volume":"196","author":"Nowson","year":"2012","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.schres.2021.08.001_bb0215","first-page":"1","article-title":"Risk of psychotic disorders in migrants to Australia","author":"O'Donoghue","year":"2020","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2021.08.001_bb0220","first-page":"1","article-title":"Emigration and insanity","author":"\u00d6degaard","year":"1932","journal-title":"Acta Psychiatr. Neurol. Scand."},{"issue":"3","key":"10.1016\/j.schres.2021.08.001_bb0225","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000504577","article-title":"Vitamin D and neurotrophin levels and their impact on the symptoms of schizophrenia","volume":"79","author":"Peitl","year":"2020","journal-title":"Neuropsychobiology"},{"issue":"1","key":"10.1016\/j.schres.2021.08.001_bb0230","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1600-0447.2005.00742.x","article-title":"The incidence and prevalence of schizophrenia varies with latitude","volume":"114","author":"Saha","year":"2006","journal-title":"Acta Psychiatr. Scand."},{"issue":"1","key":"10.1016\/j.schres.2021.08.001_bb0235","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/gbb.12271","article-title":"Developmental vitamin D deficiency and schizophrenia: the role of animal models","volume":"15","author":"Schoenrock","year":"2016","journal-title":"Genes Brain Behav."},{"issue":"4","key":"10.1016\/j.schres.2021.08.001_bb0240","first-page":"941","article-title":"Effectiveness of vitamin D supplement therapy in chronic stable schizophrenic male patients: a randomized controlled trial","volume":"15","author":"Sheikhmoonesi","year":"2016","journal-title":"Iran. J. Pharm. Res."},{"issue":"2","key":"10.1016\/j.schres.2021.08.001_bb0245","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.pscychresns.2015.06.006","article-title":"Serum vitamin D and hippocampal gray matter volume in schizophrenia","volume":"233","author":"Shivakumar","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2021.08.001_bb0250","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.schres.2021.08.001_bb0255","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1177\/0004867416681853","article-title":"Prevalence and correlates of suboptimal vitamin D status in people living with psychotic disorders: data from the Australian Survey of High Impact Psychosis","volume":"51","author":"Suetani","year":"2017","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.schres.2021.08.001_bb0260","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archpsyc.1977.01770210079007","article-title":"Seasonality of schizophrenic births in the United States","volume":"34","author":"Torrey","year":"1977","journal-title":"Arch. Gen. Psychiatry"},{"issue":"10","key":"10.1016\/j.schres.2021.08.001_bb0265","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1210\/jc.2014-1887","article-title":"Serum vitamin D levels in relation to schizophrenia: a systematic review and meta-analysis of observational studies","volume":"99","author":"Valipour","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.schres.2021.08.001_bb0270","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1017\/S0033291719001739","article-title":"Vitamin D concentration and psychotic disorder: associations with disease status, clinical variables and urbanicity","volume":"50","author":"van der Leeuw","year":"2020","journal-title":"Psychol. Med."},{"issue":"6","key":"10.1016\/j.schres.2021.08.001_bb0275","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/schbul\/sbs096","article-title":"Meta-analysis of the association of urbanicity with schizophrenia","volume":"38","author":"Vassos","year":"2012","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2021.08.001_bb0280","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/08039488.2019.1582697","article-title":"Klotho, vitamin D and homocysteine levels during acute episode and remission periods in schizophrenia patients","volume":"73","author":"Yazici","year":"2019","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.schres.2021.08.001_bb0285","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.psychres.2016.07.003","article-title":"Association between serum levels of bioavailable vitamin D and negative symptoms in first-episode psychosis","volume":"243","author":"Yee","year":"2016","journal-title":"Psychiatry Res."},{"issue":"6","key":"10.1016\/j.schres.2021.08.001_bb0290","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/2045125314553612","article-title":"Correlation between total vitamin D levels and psychotic psychopathology in patients with schizophrenia: therapeutic implications for add-on vitamin D augmentation","volume":"4","author":"Yuksel","year":"2014","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.schres.2021.08.001_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.112959","article-title":"Vitamin D deficiency and schizophrenia in adults: a systematic review and meta-analysis of observational studies","volume":"288","author":"Zhu","year":"2020","journal-title":"Psychiatry Res."},{"issue":"11","key":"10.1016\/j.schres.2021.08.001_bb0300","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1080\/1028415X.2019.1580830","article-title":"Cognition and physical functioning in patients with schizophrenia: any role for vitamin D?","volume":"23","author":"Zoghbi","year":"2020","journal-title":"Nutr. Neurosci."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996421003169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996421003169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:44:30Z","timestamp":1760298270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996421003169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":60,"alternative-id":["S0920996421003169"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2021.08.001","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between vitamin D and symptom domains in psychotic disorders: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2021.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}